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Abstract
Aims: Strains of Trichoderma spp. produce numerous bioactive secondary
metabolites. The in vitro production and antibiotic activities of the major com-
pounds synthesized by Trichoderma harzianum strains T22 and T39 against
Leptosphaeria maculans, Phytophthora cinnamomi and Botrytis cinerea were eval-
uated. Moreover, the eliciting effect of viable or nonviable biomasses of Rhizoc-
tonia solani, Pythium ultimum or B. cinerea on the in vitro production of these
metabolites was also investigated.
Methods and Results: T22azaphilone, 1-hydroxy-3-methyl-anthraquinone, 1,8-
dihydroxy-3-methyl-anthraquinone, T39butenolide, harzianolide, harzianopyri-
done were purified, characterized and used as standards. In antifungal assays,
T22azaphilone and harzianopyridone inhibited the growth of the pathogens
tested even at low doses (1–10 lg per plug), while high concentrations of
T39butenolide and harzianolide were needed (>100 lg per plug) for inhibition.
The in vitro accumulation of these metabolites was quantified by LC ⁄MS.
T22azaphilone production was not enhanced by the presence of the tested
pathogens, despite its antibiotic activity. On the other hand, the anthraquinon-
es, which showed no pathogen inhibition, were stimulated by the presence of
P. ultimum. The production of T39butenolide was significantly enhanced by
co-cultivation with R. solani or B. cinerea. Similarly, viable and nonviable bio-
masses of R. solani or B. cinerea increased the accumulation of harzianopyri-
done. Finally, harzianolide was not detected in any of the interactions
examined.
Conclusions: The secondary metabolites analysed in this study showed different
levels of antibiotic activity. Their production in vitro varied in relation to: (i)
the specific compound; (ii) the phytopathogen used for the elicitation; (iii) the
viability of the elicitor; and (iv) the balance between elicited biosynthesis and
biotransformation rates.
Significance and Impact of the Study: The use of cultures of phytopathogens
to enhance yields of Trichoderma metabolites could improve the production
and application of novel biopesticides and biofertilizers based on the active
compounds instead of the living microbe. This could have a significant benefi-
cial impact on the management of diseases in crop plants.
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Introduction
Fungal strains of the genus Trichoderma are important
biocontrol agents successfully applied as biopesticides
worldwide, and are well-known producers of secondary
metabolites with antibiotic activity (Sivasithamparam and
Ghisalberti 1998; Reino et al. 2008; Vinale et al. 2008a).
Trichoderma spp. are known to be involved in complex
interactions with host plants and resident microbial com-
munities, which include an often beneficial combination
of antibiosis and other mechanisms, such as mycoparasit-
ism, competition for nutrients ⁄ space, promotion of plant
growth and induction of systemic resistance (Harman
and Kubicek 1998; Benı´tez et al. 2004; Harman et al.
2004; Vinale et al. 2008a). The involvement of secondary
metabolites in the ability of Trichoderma spp. to activate
plant defence mechanisms and regulate plant growth has
been recently studied in depth (Vinale et al. 2008b).
Microbial secondary metabolites are produced during
microbial development and sporulation, and are among
the most important natural products used to inhibit
microbial growth (Sekiguchi and Gaucher 1977; Maple-
ston et al. 1992; Stone and Williams 1992; Vinale et al.
2008a). The spectrum of secondary metabolites secreted
by Trichoderma is species- and strain-dependent and
includes volatile and nonvolatile antifungal substances
(Sivasithamparam and Ghisalberti 1998). In a recent
paper, we reported the isolation and characterization of
the major secondary metabolites produced by Trichoder-
ma harzianum T22 and T39, two commercial strains suc-
cessfully used as biopesticides and biofertilizers in
greenhouse and open field production (Vinale et al.
2006).
In the present work, we tested the antibiotic activities
of the major secondary metabolites synthesized by T. har-
zianum strain T22 and T39 against the fungal pathogens
Leptosphaeria maculans, Phytophthora cinnamomi and
Botrytis cinerea. We also determined their in vitro produc-
tion during the interaction with various fungal pathogens
by using LC ⁄MS analysis, and evaluated the usefulness of
viable and nonviable pathogen biomasses to elicit second-
ary metabolites production in T. harzianum.
Materials and methods
Fungal strains and culture conditions
The fungal pathogens R. solani, P. ultimum, B. cinerea
and P. cinnamomi as well as the antagonistic strains T22
and T39 of T. harzianum were maintained on potato dex-
trose agar (PDA) slants at room temperature and subcul-
tured bimonthly during the study. Similarly, L. maculans
isolate UWA P11 was grown on V8 agar plates and
cultured as above. The pathogens were isolated from field
crops in Italy.
Production and characterization of secondary
metabolites
The filtered culture broths of T. harzianum strains T22
and T39 were prepared as previously described (Vinale
et al. 2006). Major secondary metabolites were extracted
and characterized according to the protocol described by
Vinale et al. (2006), quantified by LC ⁄MS and then used
as pure standards.
Plate antifungal assays
The antifungal activity of the purified Trichoderma com-
pounds was tested in vitro against the fungal pathogens
L. maculans, P. cinnamomi and B. cinerea, as described by
Vinale et al. (2006). Briefly, agar plugs cut from actively
growing margins of each pathogen colony were placed at
the centre of one-fifth strength PDA plates. Purified com-
pounds (10 ll) dissolved in filter sterilized ethyl acetate
(EtOAc) at concentrations ranging from 0Æ01 to 200 lg
per plug was applied on top of each plug and the solvent
was left to completely evaporate under a laminar flow.
The controls included the application of 10 ll of the sol-
vent alone. The pathogen growth was measured daily and
reported as colony diameter (mm). Each treatment con-
sisted of three replicates and each experiment was
repeated twice.
Co-cultures of Trichoderma and fungal pathogens
Four 7 mm diameter plugs of each Trichoderma and
pathogen (R. solani, P. ultimum, B. cinerea) strain,
obtained from actively growing margins of PDA cultures,
were co-inoculated into 500-ml conical flasks containing
100 ml sterile one-fifth strength potato dextrose broth
(PDB). The stationary cultures were incubated for 30 days
at 25C. Broth cultures of T. harzianum without fungal
pathogens served as controls.
Trichoderma cultures in the presence of nonviable
pathogen biomasses
Trichoderma harzianum inoculum was prepared as
reported above. The fungal pathogens R. solani and
P. ultimum were grown in PDB at 25C stirring at
120 rev min)1. After 7 days, the mycelia were separately
harvested, sterilized (120C for 30 min) and freeze-dried.
The sterilized mycelia were then ground in a mortar to
obtain a fine powder and added separately to the broth at
a concentration of 10 g l)1. To prepare the cell walls of
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B. cinerea, the fungal mycelium was scraped from PDA
dishes and homogenized in 10 volumes of 0Æ1% (w ⁄ v)
SDS. Purification of cell walls was carried out as reported
by Messner and Kubicek (1990). The purified cell walls
were ground to a fine powder under liquid nitrogen and
added to the broth at a concentration of 10 g l)1. Culture
broths of T. harzianum without amendment with fungal
pathogens were used as controls.
Production of secondary metabolites in the pres-
ence of viable or nonviable pathogen biomasses
The production of major secondary metabolites by
T. harzianum in liquid cultures amended with viable
(living mycelium) or nonviable (sterilized mycelium or
cell walls) biomass of different fungal pathogens
(R. solani, P. ultimum, B. cinerea) was evaluated. The sta-
tionary cultures were incubated for 30 days at 25C and
then filtered under vacuum. The filtered broths were
extracted exhaustively with EtOAc. The combined organic
fractions were dried with Na2SO4 and evaporated under
reduced pressure at 35C. The recovered residues were
re-suspended in methanol and subjected to LC ⁄MS analy-
sis for the quantification of metabolites.
Chromatographic separation was performed using an
HPLC apparatus equipped with two Micropumps Series
200 (Perkin Elmer, Shelton, CT, USA), and a Gemini
5 lm C18 110 A column (150 · 42 mm) (Phenomenex,
Torrance, CA, USA). The eluents were A = water +0Æ1%
formic acid, and B = methanol. The gradient program for
T22azaphilone, 1-hydroxy-3-methyl-anthraquinone and
1,8-dihydroxy-3-methyl-anthraquinone was as follows:
40–100% B (8 min), 100% B (2 min) at a constant flow
of 0Æ2 ml min)1. The gradient program for T39buteno-
lide, harzianolide and harzianopyridone was as follows:
50–100% B (10 min), 100% B (3 min) at a constant flow
of 0Æ2 ml min)1. Injection volume was 20 ll.
Mass spectrometry (MS) analyses were performed on
an API 3000 triple quadrupole mass spectrometer
(Applied Biosystems, Toronto, Canada) equipped with a
heated nebulizer source working in the positive or nega-
tive ion mode. Only for T22azaphilone a TurboIonspray
source was used. Acquisitions were performed using a
multiple reaction monitoring (MRM) approach. Specific
transitions (precursor and product ions) for each meta-
bolite are also monitored as reported in Table 1.
Results
The major secondary metabolites (1–6; Fig. 1) obtained
from culture filtrates of T22 and T39 Trichoderma strains
were purified and characterized as previously reported
(Vinale et al. 2006). In plate antifungal assays, 1–10 lg of
T22azaphilone (1; Fig. 1) completely inhibited the growth
of the fungal pathogens P. cinnamomi, B. cinerea and
L. maculans (Fig. 2). This is in agreement with the inhibi-
tory effect of 1–100 lg of T22azaphilone on Gaeumanno-
myces graminis var. tritici, R. solani and P. ultimum
(Vinale et al. 2006). Anthraquinones (2, 3; Fig. 1), instead,
demonstrated no antifungal activity against P. cinnamomi,
B. cinerea and L. maculans (data not shown), as previously
reported for R. solani and P. ultimum (Vinale et al. 2006).
Relatively to the secondary metabolites isolated from
T. harzianum T39, the most effective was the harziano-
pyridone, which exhibited in the same plate assay 100%
growth inhibition of L. maculans and P. cinnamomi at 1
and 100 lg application rate, respectively (Fig. 2). T39but-
enolide (4; Fig. 1) was able to completely stop the growth
of L. maculans and P. cinnamomi (Fig. 2), as well as that
of G. graminis var. tritici and R. solani at 100 lg (Vinale
et al. 2006). Finally, harzianolide (5; Fig. 1) showed less
Table 1 LC ⁄ MS transitions monitored for each metabolite by multi-
ple reaction monitoring
Metabolite
Precursor ion
[M + H]+m ⁄ z
Product ions
[M + H]+m ⁄ z
Positive ion mode
T22azaphilone 345 259, 241
1-Hydroxy-3-methyl-
anthraquinone
239 211
1,8-Dihydroxy-3-methyl-
anthraquinone
255 209
T39butenolide 221 203, 157, 133
Harzianolide 222 204, 158, 134
Negative ion mode
Metabolite Precursor ion
[M – H])m ⁄ z
Product ions
[M – H])m ⁄ z
Harzianopyridone 280 250, 265, 183
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Figure 1 Trichoderma secondary metabolites. 1: T22azaphilone; 2: 1-
hydroxy-3-methyl-anthraquinone; 3: 1,8-dihydroxy-3-methyl-anthra-
quinone; 4: T39butenolide; 5: harzianolide; 6: harzianopyridone.
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than 25% growth inhibition at the maximum application
rate of 200 lg (Fig. 2).
The isolated secondary metabolites were used as pure
standards in LC ⁄MS-based quantification of the amount
of these compounds accumulated in the medium during
in vitro interaction of Trichoderma with fungal pathogens
(examples shown in Fig. 3). For these experiments R. so-
lani, P. ultimum and B. cinerea were used because of their
economical importance in agriculture and the very differ-
ent response to the tested metabolites, as determined also
in an earlier work (Vinale et al. 2006). The production of
major secondary metabolites by T. harzianum in liquid
cultures was differently affected by the presence of viable
or nonviable biomasses of the three phytopathogens
tested. Among the compounds produced in liquid co-cul-
tures by T. harzianum strain T22, no significant
differences were found in the accumulation of T22azaphi-
lone between control and R. solani- or B. cinerea-treated
samples (Table 2). Instead, the presence of nonviable bio-
masses of the pathogens, as well as the co-culture with
the living mycelium of P. ultimum, significantly reduced
or completely inhibited T22azaphilone production com-
pared to the untreated control. Interestingly, the secretion
of anthraquinones (2, 3; Fig. 1) was elicited by the inter-
action with both viable and nonviable P. ultimum bio-
masses, but not by the other treatments.
Co-cultures of T. harzianum strain T39 and R. solani
or B. cinerea enhanced the production of T39butenolide,
but there was no difference compared to controls
containing nonviable pathogen biomasses (Table 2).
Similarly, R. solani and B. cinerea stimulated the accumu-
lation of harzianopyridone during the interaction of
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Figure 2 Antibiotic activity of the purified
Trichoderma secondary metabolites: ( )
Leptosphaeria maculans; ( ) Phytophthora
cinnamomi; ( ) Botrytis cinerea. Concentra-
tions ranging from 0Æ01 to 200 lg per plug.
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Figure 3 (a) LC ⁄ MS of extracts obtained from control (T22 alone – black) and co-culture of Trichoderma harzianum T22 and Botrytis cinerea
(red); (b) LC ⁄ MS of extracts obtained from control (T39 alone – red) and co-cultures of T. harzianum T39 and Rhizoctonia solani (black).
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T. harzianum with both living and dead fungal pathogens.
Finally, harzianolide was not induced nor detected in any
of our experiments (data not shown).
Discussion
Production of secondary metabolites in fungi is a com-
plex process associated with morphological development
(Calvo et al. 2002). Secondary metabolites are of tremen-
dous importance in biotechnological applications, but in
some cases seem not to have clear function for the pro-
ducing microbe. In a previous work, we analysed the
major secondary metabolites produced by two commer-
cial strains (T22 and T39) of T. harzianum (Vinale et al.
2006). Six compounds (1–6) obtained from fungal culture
filtrates were isolated and characterized. These metabolites
showed different levels of antibiotic activity against the
fungal pathogens G. graminis var. tritici, R. solani and
P. ultimum (Vinale et al. 2006). In this paper, their anti-
fungal activity against other important phytopathogens
such as L. maculans (causal agent of the blackleg disease
on crucifers), P. cinnamomi (causal agent of the forest
dieback disease), B. cinerea (causal agent of various grey
mould diseases) is reported. Both T22azaphilone and har-
zianopyridone produced by T. harzianum strain T22
showed a broad spectrum of activity even if applied at
low concentrations (approx. 1–10 lg per plug in a stan-
dard plate assay), while T39butenolide and harzianolide
secreted by strain T39 significantly inhibited pathogens
growth only when used at higher concentrations
(approx. > 100 lg per plug; Fig. 2). These data confirmed
and contributed to our knowledge of the spectrum of
antifungal activity of these secondary metabolites (Vinale
et al. 2006).
We also quantified by LC ⁄MS the production of T22
and T39 secondary metabolites in liquid cultures
amended with viable or nonviable pathogen biomasses.
Interestingly, in T. harzianum strain T22 the interaction
with fungal pathogens seemed not to be correlated with
the accumulation of antibiotic compounds. In fact, the
secretion of T22azaphilone, a compound that demon-
strated strong antifungal activity in vitro, was not particu-
larly induced in co-culture with R. solani or B. cinerea,
and appeared to be even repressed when nonviable patho-
gen biomass or P. ultimum living mycelia were applied
(Table 2). Conversely, increased amounts of anthraqui-
nones were found in P. ultimum-treated samples, even
though these compounds did not demonstrate significant
antifungal properties. Similarly, Donnelly and Sherida
(1986) isolated anthraquinones in elicited co-culture of
T. polysporum and Heterobasidion annosum, but no
marked inhibition of pathogen growth was observed. In
fact, anthraquinones are pigments and have been consid-
ered among the most abundant fungal natural products
giving colour to spores, appressoria, sclerotia, sexual
bodies and other developmental structures (Yu and Keller
2005). In addition because of their chemical structure, an-
thraquinones could act as ROS scavengers in Trichoderma
Table 2 Production of secondary metabolites
(lg) by Trichoderma harzianum strains T22
and T39 during the interaction with fungal
pathogen
Treatment
Produced compounds (lg)
Trichoderma harzianum strain T22
Trichoderma harzianum
strain T39
T22azaphilone
1-Hydroxy-3-
methyl-
anthraquinone
1,8-Dihydroxy-3-
methyl-
anthraquinone
T39
butenolide Harzianopyridone
Control 372 ± 60 260 ± 40 114 ± 30 508 ± 50 52 ± 20
Co-culture
Rhizoctonia
solani
326 ± 50 114 ± 30 93 ± 30 1700 ± 150 212 ± 30
Pythium
ultimum
6 ± 1 542 ± 30 260 ± 5 450 ± 50 4 ± 1
Botrytis
cinerea
302 ± 40 157 ± 40 88 ± 20 850 ± 60 158 ± 30
Nonviable
biomass
R. solani 8 ± 2 15 ± 2 8 ± 1 401 ± 70 85 ± 5
P. ultimum nd 1060 ± 200 357 ± 10 475 ± 30 3 ± ±1
B. cinerea nd 134 ± 10 39 ± 20 357 ± 25 169 ± 30
nd: not detected. Co-culture: T. harzianum + living mycelium of R. solani, P. ultimum or B. cine-
rea. Nonviable biomass: Trichoderma + lyophilized R. solani or P. ultimum mycelia (10 g l)1), or
Trichoderma + B. cinerea cell walls (10 g l)1). Control: Trichoderma alone. Quantification per-
formed by LC ⁄ MS analysis. Values are means of three replicates (±SD).
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and their accumulation could be stimulated by using
appropriate elicitors (i.e. fungal pathogen biomasses) to
increase resistance of beneficial strains against biotic or
abiotic stresses (Yu and Keller 2005).
T39butenolide and harzianopyridone production was
elicited in co-cultures with B. cinerea and R. solani. In
contrast, harzianolide, a reduced form of T39butenolide,
was not detected in the interactions between T. harzia-
num strain T39 and pathogen biomasses, as previously
observed in plate confrontation assays with R. solani (Vi-
nale et al. 2006). Serrano-Carreo`n et al. (2004) found that
the production of 6-pentyl-a-pyrone (6PP) was stimu-
lated by the cultivation with nonviable pathogen myce-
lium, but not in the co-culture condition. Therefore, they
suggested that 6PP production in T. harzianum is elicited
by R. solani as an antagonistic response determined by
the physiological status of the host.
It has been demonstrated that virulent phytopathogenic
fungi are able to bio-transform metabolites which would
otherwise be toxic (Zikmundova et al. 2002). This strat-
egy helps pathogens to overcome host defences (i.e. anti-
biotics produced by plants) or to withstand adverse
environmental conditions, such as those where toxic com-
pounds are produced by antagonistic agents (Bowyer
et al. 1995; Friebe et al. 1998). Different fungal pathogens
can transform the Trichoderma 6PP into isomeric mix-
tures of monohydroxylated derivates or, in some cases,
into carboxylic acids by further oxidation (Cooney et al.
1997; Poole and Whitaker 1997; Cooney and Lauren
1999). Therefore, the quantity of secondary metabolites
accumulated by Trichoderma in co-cultures with fungal
pathogens depends on the balance between the eliciting
effect and the rate of biotransformation exerted by the
host pathogen.
Our data indicate that the amount of secondary metab-
olites produced in T. harzianum may depend on the state
of the host as well as on the following important factors:
(i) the strain considered; (ii) the eliciting microbe or con-
dition; and (iii) the balance between biosynthesis and bio-
transformation of the metabolite. The understanding and
manipulation of the above issues will improve the pro-
duction process of natural compounds secreted by antag-
onistic fungi or other microbes. The direct application of
the relative eliciting molecules may represent a novel
approach to develop biopesticides and biofertilizers based
on bioactive compounds.
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